PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Amirhossein Hasanpour

Research Institute for Endocrine Sciences

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs1 Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · JOURNAL ARTICLE

Measures of obesity and first atherosclerotic cardiovascular events in stage 0 cardiovascular-kidney-metabolic syndrome: Tehran lipid and glucose study

Diabetology & Metabolic Syndrome

Prospective cohort study with 19.6-year median follow-up, hard clinical endpoint (incident ASCVD), and consistent dose–response relationships across multiple abdominal obesity measures with statistical significance and robust sensitivity analyses.

Strong EvidenceFereidoun Azizi Farzad Hadaegh Navid Ebrahimi

Reported

Sample size691

Number with incident ASCVD58

Incidence proportion8.4%

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support